AGP products and prices in Pakistan
Manufacturer & importer Has products under both a manufacturing licence (DML) and a sale licence (DSL). Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Public pharmaceutical manufacturer · Karachi · Pakistan
Pakistan pharmaceutical manufacturer operating since 1989, producing and marketing proprietary brands and licensed products.
AGP products in Pakistan
AGP Limited has 220 medicine presentations registered in Pakistan under 81 brands, covering 68 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Oncology & immunology. Its brands with the most registered strengths and packs are Neogene (Ceftriaxone), AMOXI-CLAV (Amoxicillin + clavulanic acid), OSPAMOX (Amoxicillin) and TRUGLIF (Empagliflozin). 220 products have an official DRAP price on MedInfoBase. See all 81 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Public pharmaceutical manufacturer
- Address
- B-23-C, S.I.T.E. Area, Karachi-75700, Pakistan · 75700
- Website
- agp.com.pk ↗
- Phone
- +92 21 111 247 247
- info@agp.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where AGP Limited is priced against the market
177 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| No matching products. | ||||||||
All 81 AGP brands in Pakistan
- ABEVMY Bevacizumab · 100 mg/4 mL infusion
- Abevmy 400 Bevacizumab · 400 mg/16 mL (25 mg/mL) infusion
- ACLASTA Zoledronic acid · 5 mg/100 mL infusion
- ACOZAR Losartan · 100 MG tablet, 25 mg tablet, 50 mg tablet
- ACTOLAZE Lactulose · 3.35 g/5 mL syrup
- Agfo Tenofovir disoproxil · 300 mg tablet
- ALGOCIN Ciprofloxacin · 200 mg/100 mL infusion, 250 MG tablet, 500 mg tablet
- AMOXI-CLAV Amoxicillin + clavulanic acid · 125 mg + 31.25 mg / 5 mL suspension, 125 mg + 31.25 mg/5 mL suspension, 250 mg + 125 mg tablet
- AVONZA Tenofovir disoproxil · 300 mg tablet
- Axcin Ciprofloxacin · 250 mg tablet, 500 mg tablet
- AZOMAX Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
- BETADINE ANTISEPTIC Povidone-iodine · 10 % solution, 10% solution
- BETADINE GARGLE & MOUTHWASH Povidone-iodine · 1.10 % mouthwash, 1.10% mouthwash
- BETADINE SURGICAL SCRUB Povidone-iodine · 9.00 % surgical scrub, 9.00% surgical scrub
- BISPA Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- CAP-ITRA Itraconazole · 100 mg capsule
- Cinklare Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- CLANDOGEN Clomifene citrate · 50 MG tablet
- CLARAMED Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 MG tablet
- CLOMFRANIL Clomipramine · 10 mg tablet, 25 mg tablet
- CLOZARIL Clozapine · 100 MG tablet, 25 mg tablet
- CO-MALEDOX Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 40 mg + 240 mg capsule
- COFIF Lamivudine + Zidovudine · 150 mg + 300 mg tablet
- Dermazin Silver sulfadiazine · 1 % cream, 1% w/w cream, 10 mg/g (1%) cream
- DIMPLE Medroxyprogesterone acetate · 150 mg/mL injection
- DIODERM Betamethasone dipropionate · 0.50 mg cream
- DOLOFEN Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 400 mg tablet
- DOLUTEGRAVIR Dolutegravir · 50 mg tablet
- Doxorubicin Ebewe Doxorubicin · 10 mg/5 mL (2 mg/mL) infusion, 50 mg/25 mL (2 mg/mL) infusion
- Duplanon Levonorgestrel · 75 mg implant
- Ebedoce Docetaxel · 20 mg/2 mL (10 mg/mL) infusion, 80 mg/8 mL (10 mg/mL) infusion
- EMEREP Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
- FULPHILA Pegfilgrastim · 6 mg/0.6 mL injection
- GEMCITABIN EBEWE Gemcitabine · 1 g/100 mL (10 mg/mL) infusion, 200 mg/20 mL (10 mg/mL) infusion
- GLUCONORM Gliclazide · 80 mg tablet
- HEPBEST Tenofovir disoproxil · 25 mg tablet
- Hertraz Trastuzumab · 150 mg infusion, 440 mg infusion
- JORMIA Metformin · 1000 mg tablet, 500 mg tablet, 850 mg tablet
- JORMIA-XR Metformin · 1000 mg tablet, 500 mg tablet, 750 mg tablet
- Keflex Cephalexin · 100 mg drops, 125 mg/5 mL suspension, 250 mg capsule
- KEFZOL Cefazolin · 1 g injection, 500 MG injection
- Lectrum Leuprorelin acetate · 3.75 MG injection, 7.5 mg injection
- LEDVIR 90MG Sofosbuvir · 90 mg tablet
- LEVOFIN Levofloxacin · 250 MG tablet, 500 MG tablet
- Lipitor Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- LOPINAVIR/RITONAVIR Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- LUNAOLE Letrozole · 2.5 mg tablet
- MAGNO-P Paracetamol · 120 mg/5 mL syrup, 120 mg/5 mL suspension, 500 mg tablet
- MAGNUS MR Morphine · 10 mg capsule, 30 mg capsule
- MAGVAL Magnesium Valproate · 100 mg tablet, 200 mg tablet, 500 mg tablet
- MALEDOX Artemether · 80 MG/mL injection
- MAXNA Tranexamic acid · 100 mg/mL injection, 250 mg/5 mL injection, 500 mg/5 mL injection
- MI-PENEM Meropenem · 1 g injection, 500 mg injection
- MST CONTINUS Morphine · 10 mg tablet, 30 mg tablet
- MYDEKLA Daclatasvir · 30 mg tablet, 60 mg tablet
- MYHEP Sofosbuvir · 400 mg tablet
- MYHEP ALL Sofosbuvir · 400 mg tablet
- Neogene Ceftriaxone · 1 g injection, 1.0 g injection, 2 g injection
- NEVIMAT Nevirapine · 200 MG tablet
- NORDEP Fluoxetine · 20 mg capsule
- Norvasc Amlodipine · 10 mg tablet, 5 mg tablet
- Ondansetron-Sandoz Ondansetron · 8 mg/4 mL injection
- OSPAMOX Amoxicillin · 1000 mg tablet, 125 MG/5 mL suspension, 250 MG/5 mL suspension
- Oxaliplatin Ebewe Oxaliplatin · 100 mg/20 mL (5 mg/mL) infusion, 150 mg/30 mL (5 mg/mL) infusion, 50 mg/10 mL (5 mg/mL) infusion
- Paclitaxel Ebewe Paclitaxel · 100 mg/16.7 mL (6 mg/mL) infusion, 150 mg/25 mL (6 mg/mL) infusion, 30 mg/5 mL (6 mg/mL) infusion
- PENTOFUR INJETION Suxamethonium chloride · 2 % injection
- PRAZIN Omeprazole · 20 mg capsule, 40 mg capsule
- QPIDO Clopidogrel · 75 mg tablet
- QUVASC Amlodipine · 10 mg tablet, 2.5 mg tablet
- RICOVIR EM Emtricitabine · 200 mg tablet
- TINASIL Terbinafine · 10 mg cream
- TRUGLIF Empagliflozin · 10 mg tablet, 25 mg tablet
- VALRATE Divalproex sodium · 250 mg tablet, 500 mg tablet, 500 MG injection
- VIRABIN Ribavirin · 400 mg tablet, 600 mg tablet
- Xalatan Latanoprost · 50 mcg/mL (0.005%) drops
- XITON Risperidone · 1 mg tablet, 2 MG tablet, 3 mg tablet
- XOTIVIR Entecavir · 0.5 mg tablet, 1 mg tablet
- Zenicin Amikacin · 100 mg/2 mL injection, 250 MG injection, 500 mg/2 mL injection
- Zofran Ondansetron · 8 mg tablet, 8 mg/4 mL injection
- ZOPH Quetiapine · 100 mg tablet, 200 mg tablet, 25 mg tablet
- ZOPH XR Quetiapine · 150 MG tablet, 200 mg tablet, 300 MG tablet
AGP: common questions
How many products does AGP have in Pakistan?
AGP Limited has 220 registered medicine presentations in Pakistan, sold under 81 brands and covering 68 generic medicines.
What are the main brands of AGP?
By number of registered strengths and packs, its largest brands are Neogene (Ceftriaxone), AMOXI-CLAV (Amoxicillin + clavulanic acid), OSPAMOX (Amoxicillin), TRUGLIF (Empagliflozin) and Keflex (Cephalexin). This is not a sales ranking.
Which therapy areas does AGP cover?
The most products are in Anti-infectives (108), CNS & mental health (24), Oncology & immunology (18), Endocrine & metabolic (16) and Cardiovascular (15).
Where can I see AGP medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.